FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3091948906> ?p ?o ?g. }

• W3091948906 endingPage "104051" @default.
• W3091948906 startingPage "104051" @default.
• W3091948906 abstract "SARS-CoV-2 has ushered a global pandemic with no effective drug being available at present. Although several FDA-approved drugs are currently under clinical trials for drug repositioning, there is an on-going global effort for new drug identification. In this paper, using multi-omics (interactome, proteome, transcriptome, and bibliome) data and subsequent integrated analysis, we present the biological events associated with SARS-CoV-2 infection and identify several candidate drugs against this viral disease. We found that: (i) Interactome-based infection pathways differ from the other three omics-based profiles. (ii) Viral process, mRNA splicing, cytokine and interferon signaling, and ubiquitin mediated proteolysis are important pathways in SARS-CoV-2 infection. (iii) SARS-CoV-2 infection also shares pathways with Influenza A, Epstein-Barr virus, HTLV-I, Measles, and Hepatitis virus. (iv) Further, bacterial, parasitic, and protozoan infection pathways such as Tuberculosis, Malaria, and Leishmaniasis are also shared by this virus. (v) A total of 50 candidate drugs, including the prophylaxis agents and pathway specific inhibitors are identified against COVID-19. (vi) Betamethasone, Estrogen, Simvastatin, Hydrocortisone, Tositumomab, Cyclosporin A etc. are among the important drugs. (vii) Ozone, Nitric oxide, plasma components, and photosensitizer drugs are also identified as possible therapeutic candidates. (viii) Curcumin, Retinoic acids, Vitamin D, Arsenic, Copper, and Zinc may be the candidate prophylaxis agents. Nearly 70% of our identified agents are previously suggested to have anti-COVID-19 effects or under clinical trials. Among our identified drugs, the ones that are not yet tested, need validation with caution while an appropriate drug combination from these candidate drugs along with a SARS-CoV-2 specific antiviral agent is needed for effective COVID-19 management." @default.
• W3091948906 created "2020-10-15" @default.
• W3091948906 creator A5017249124 @default.
• W3091948906 creator A5046879365 @default.
• W3091948906 creator A5068391234 @default.
• W3091948906 creator A5069429361 @default.
• W3091948906 creator A5080886331 @default.
• W3091948906 creator A5088242467 @default.
• W3091948906 creator A5088728429 @default.
• W3091948906 date "2020-11-01" @default.
• W3091948906 modified "2023-10-18" @default.
• W3091948906 title "Multi-omics-based identification of SARS-CoV-2 infection biology and candidate drugs against COVID-19" @default.
• W3091948906 cites W1964846721 @default.
• W3091948906 cites W1995121548 @default.
• W3091948906 cites W2052685738 @default.
• W3091948906 cites W2074114926 @default.
• W3091948906 cites W2124649657 @default.
• W3091948906 cites W2142879323 @default.
• W3091948906 cites W2170146596 @default.
• W3091948906 cites W2180848504 @default.
• W3091948906 cites W2345356016 @default.
• W3091948906 cites W2559588208 @default.
• W3091948906 cites W2588967599 @default.
• W3091948906 cites W2892339436 @default.
• W3091948906 cites W2900044275 @default.
• W3091948906 cites W2935024989 @default.
• W3091948906 cites W2946173685 @default.
• W3091948906 cites W3001897055 @default.
• W3091948906 cites W3002108456 @default.
• W3091948906 cites W3002539152 @default.
• W3091948906 cites W3003217347 @default.
• W3091948906 cites W3005212621 @default.
• W3091948906 cites W3008142620 @default.
• W3091948906 cites W3010673910 @default.
• W3091948906 cites W3013843138 @default.
• W3091948906 cites W3014185271 @default.
• W3091948906 cites W3014705243 @default.
• W3091948906 cites W3015232424 @default.
• W3091948906 cites W3015807479 @default.
• W3091948906 cites W3016489853 @default.
• W3091948906 cites W3017352783 @default.
• W3091948906 cites W3018048153 @default.
• W3091948906 cites W3019378402 @default.
• W3091948906 cites W3020749996 @default.
• W3091948906 cites W3021836169 @default.
• W3091948906 cites W3022285953 @default.
• W3091948906 cites W3023269498 @default.
• W3091948906 cites W3023713343 @default.
• W3091948906 cites W3024403307 @default.
• W3091948906 cites W3025226065 @default.
• W3091948906 cites W3025986507 @default.
• W3091948906 cites W3026002191 @default.
• W3091948906 cites W3026232146 @default.
• W3091948906 cites W3027093163 @default.
• W3091948906 cites W3030547479 @default.
• W3091948906 cites W3031747513 @default.
• W3091948906 cites W3031816285 @default.
• W3091948906 cites W3032118565 @default.
• W3091948906 cites W3033117555 @default.
• W3091948906 cites W3033737840 @default.
• W3091948906 cites W3038226671 @default.
• W3091948906 cites W3041142586 @default.
• W3091948906 cites W3090795730 @default.
• W3091948906 doi "https://doi.org/10.1016/j.compbiomed.2020.104051" @default.
• W3091948906 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7547373" @default.
• W3091948906 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33131530" @default.
• W3091948906 hasPublicationYear "2020" @default.
• W3091948906 type Work @default.
• W3091948906 sameAs 3091948906 @default.
• W3091948906 citedByCount "71" @default.
• W3091948906 countsByYear W30919489062020 @default.
• W3091948906 countsByYear W30919489062021 @default.
• W3091948906 countsByYear W30919489062022 @default.
• W3091948906 countsByYear W30919489062023 @default.
• W3091948906 crossrefType "journal-article" @default.
• W3091948906 hasAuthorship W3091948906A5017249124 @default.
• W3091948906 hasAuthorship W3091948906A5046879365 @default.
• W3091948906 hasAuthorship W3091948906A5068391234 @default.
• W3091948906 hasAuthorship W3091948906A5069429361 @default.
• W3091948906 hasAuthorship W3091948906A5080886331 @default.
• W3091948906 hasAuthorship W3091948906A5088242467 @default.
• W3091948906 hasAuthorship W3091948906A5088728429 @default.
• W3091948906 hasBestOaLocation W30919489061 @default.
• W3091948906 hasConcept C103637391 @default.
• W3091948906 hasConcept C159047783 @default.
• W3091948906 hasConcept C18903297 @default.
• W3091948906 hasConcept C2780035454 @default.
• W3091948906 hasConcept C519536355 @default.
• W3091948906 hasConcept C71924100 @default.
• W3091948906 hasConcept C86803240 @default.
• W3091948906 hasConcept C98274493 @default.
• W3091948906 hasConceptScore W3091948906C103637391 @default.
• W3091948906 hasConceptScore W3091948906C159047783 @default.
• W3091948906 hasConceptScore W3091948906C18903297 @default.
• W3091948906 hasConceptScore W3091948906C2780035454 @default.
• W3091948906 hasConceptScore W3091948906C519536355 @default.
• W3091948906 hasConceptScore W3091948906C71924100 @default.
• W3091948906 hasConceptScore W3091948906C86803240 @default.

• next